- 24 h
- letzte 200 News
| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| 13.06. | BMS taps biotech analyst from Goldman Sachs to lead long-term strategy | ||
| 13.06. | Novo Nordisk plots phase 3 trials for next-gen obesity asset amycretin | ||
| 13.06. | AstraZeneca pens $5.3B pact to use CSPC's AI platform to develop oral drugs for chronic diseases | ||
| 13.06. | Astellas offers lab space to start-ups to help Japanese biotechs 'go global' | ||
| 12.06. | ADC Therapeutics shutters UK R&D site, culls several preclinical programs and trims workforce by 30% | ||
| 12.06. | Merck KGaA sheds light on failed portion of phase 2 lupus trial, keeps sights on regulators | ||
| 12.06. | GSK offloads shigella vaccine to Bharat ahead of phase 3, vows to support fundraising | ||
| 12.06. | BioNTech buys German mRNA vaccine peer CureVac in $1.2B all-stock deal | ||
| 11.06. | FDA aims for 'rapid or instant' drug reviews, with AI tool initially assessing applications | ||
| 11.06. | Genentech lays off 143 workers at South San Francisco campus | ||
| 11.06. | Vertex lays off 125 staffers, slims Rhode Island campus after ditching failed diabetes cell-device combo | ||
| 11.06. | 'The opportunities are immense': Novo Nordisk signs up to use Danish supercomputer | ||
| 11.06. | Eli Lilly works out $650M Juvena pact to find muscle-boosting drugs | ||
| 11.06. | BMS expands radiopharma pipeline via RayzeBio's $1.3B prostate cancer drug deal | ||
| 10.06. | FDA slaps clinical hold on multiple Gilead HIV combo therapy trials, shares fall | ||
| 10.06. | Scorpion spinout raises $177M to advance preclinical assets after 2 clinical programs sold to Pierre Fabre | ||
| 10.06. | Pfizer CEO talks Chinese due diligence, ADC synergies to justify $6B bet on 'fabulous' bispecific | ||
| 10.06. | Recursion lays off 20% of staff in wake of pipeline cutbacks | ||
| 10.06. | Odyssey abandons IPO plans in latest sign of tough environment for biotech listings | ||
| 10.06. | Activist investor demands Keros 'aggressively' cut costs just weeks after layoffs | ||
| 09.06. | Axsome plots new fibromyalgia trial after FDA refuses to review former Pfizer candidate | ||
| 09.06. | GSK snags long-time Sanofi exec to lead vaccine and infectious disease R&D | ||
| 09.06. | Embattled Elevation Oncology becomes latest biotech to accept Concentra buyout offer | ||
| 09.06. | Merck's leader in oral PCSK9 inhibitor race reduces cholesterol in pair of phase 3 trials | ||
| 09.06. | NewAmsterdam links lipid-lowering drug to improvement in Alzheimer's cognition biomarker |
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .